Risk of drug-induced photosensitivity: Focus on spectroscopic and molecular characteristics

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 7, 2009, Pages 602-609

  Verdel, B M ^a   Souverein, P C ^a   Meyboom, R H B ^a,b   Kardaun, S H ^c   Leufkens, H G M ^a   Egberts, A C G ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UPPSALA MONITORING CENTRE   (Sweden)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Molecular drug characteristics; Pharmacovigilance; Photosensitivity; Spectroscopy; Ultraviolet radiation

Indexed keywords

AMIODARONE; AZAPROPAZONE; BENOXAPROFEN; CARPROFEN; CHLORPROMAZINE; DEMECLOCYCLINE; DOXYCYCLINE; HYDROCHLOROTHIAZIDE; NALIDIXIC ACID; NAPROXEN;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DRUG USE; HUMAN; INCIDENCE; LIPOPHILICITY; MOLECULAR WEIGHT; PHOTOSENSITIVITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; SPECTROSCOPY;

DATABASES, FACTUAL; HUMANS; PHOTOSENSITIVITY DISORDERS; PRESCRIPTION DRUGS; RISK FACTORS; SEASONS; SPECTRUM ANALYSIS; ULTRAVIOLET RAYS; WORLD HEALTH ORGANIZATION;

EID: 69049104380     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1760     Document Type: Article

References (33)

1. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 2002; 25: 345-372.
2. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53: 357-379.
3. Vassileva SG, Mateev G, Parish LC. Antimicrobial photosensitive reactions. Arch Intern Med 1998; 158: 1993-2000.
4. Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995; 33: 551-573. DOI: 10.1016/0190-9622(95)91271-1
5. Lankerani L, Baron ED. Photosensitivity to exogenous agents. J Cutan Med Surg 2004; 8: 424-431. DOI: 10.1007.S10227-005-0017-3.
6. Ferguson J. Photosensitivity due to drugs. Photodermatol Photoimmunol Photomed 2002; 18: 262-269. DOI: 10.1034/ j.1600-0781.2002.02778.x.
7. Mulder WMC, Meinardi MMHM, Bruynzeel DP (eds). Side effects in dermatology, 8th edn. Amsterdam: Intermed Medical Publishers, 2004.
8. FDA. Guidance for industry: photosafety testing. Pharmacology toxicology coordinating committee. Rockville: Center for Drug Evaluation and Research, 2003; 1-21.
9. EMEA. Note for guidance on photosafety testing (CPMP/SWP/398/01), London: Committee for Proprietary Medicinal Products, 2002; 1-7.
10. Harber LC, Baer RL. Pathogenic mechanisms of drug-induced photosensitivity. J Invest Dermatol 1972; 58: 327-342.
11. Leblanc B, Jezequel S, Davies T, et al. Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharmacol 1998; 28: 124-132. DOI: 10.1006/rtph. 1998.1243.
12. WHO. International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology. WHO Collaborating Centre for International Drug Monitoring: Uppsala, 2007.
13. WHO. Anatomical Therapeutic Chemical (ATC) classification index. WHO Collaborating Centre for Drug statistics Methodology: Oslo, 2007.
14. Bate A, Edwards IR. Data mining in spontaneous reports. Basic Clin Pharmacol Toxicol 2006; 98: 324-330. DOI: 10.1111/ j.1742-7843.2006.pto-232.x
15. De Bruin ML, Pettersson M, Meyboom RH, et al. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 2005; 26: 590-597. DOI: 10.1093/eurheartj/ehi155
16. Litt JZ. Litt's Drug Eruption Reference Manual (10th edn), Taylor & Francis Group: London, 2004.
17. Dibbern HW, Müller RM, Wirbitzki E (eds). UV and IR Spectra of Pharmaceutical Substances and IR Spectra of Pharmaceutical and Cosmetic Excipients. Aulendorf: Editio Cantor Verlag, 2002.
18. http://chem.sis.nlm.nih.gov/chemidplus (assessed March 2007).
19. http://ibmlc2.chem.uga.edu/sparc (assessed March 2007).
20. http://www.syrres.com/esc/est_kowdemo (assessed April 2007).
21. Kollias N, Baqer AH, Ou-Yang H. Diurnal and seasonal variations of the UV cut-off wavelength and most erythemally effective wavelength of solar spectra. Photodermatol Photoimmunol Photomed 2003; 19: 89-92. DOI: 10.1034/j.1600-0781.2003.00002.x
22. Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35: 871-885. DOI: 10.1016/S0190-9622(96)90108-5
23. Brendler-Schwaab S, Czich A, Epe B, et al. Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat Res 2004; 566: 65-91. DOI: 10.106/ S1383-5742(03)00052-8
24. Jose JG. Photomutagenesis by chlorinated phenothiazine tranquilizers. Proc Natl Acad Sci U S A 1979; 76: 469-472.
25. Fasani E, Barberis Negra FF, Mella M, et al. Photoinduced C-F bond cleavage in some fluorinated 7-amino-4-quinolone-3-carboxylic acids. J Org Chem 1999; 64: 5388-5395. DOI: 10.1021/jo982456t S0022-3263(98)02456-6.
26. Selvaag E, Petersen AB, Gniadecki R, et al. Phototoxicity to diuretics and antidiabetics in the cultured keratinocyte cell line HaCaT: evaluation by clonogenic assay and single cell gel electrophoresis Comet assay). Photodermatol Photoimmunol Photomed 2002; 18: 90-95. DOI: 10.1034/j.1600-0781.2002.180206.x
27. Lumley CE,Walker SR, Hall GC, et al. The under-reporting of adverse drug reactions seen in general practice. Pharmaceut Med 1986; 1: 205-212.
28. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-396.
29. Milstien JB, Faich GA, Hsu JP, et al. Factors affecting physician reporting of adverse drug reactions. Drug Inf J 1986; 20: 157-164.
30. Martin RM, Kapoor KV, Wilton LV, et al. Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study. Br Med J 1998; 317: 119-120.
31. Quintero B, Miranda MA. Mechanisms of photosensitization induced by drugs: a general survey. Ars Pharmaceutica 2000; 41: 27-46.
32. Ferguson J, Addo HA, Jones S, et al. A study of cutaneous photosensitivity induced by amiodarone. Br J Dermatol 1985; 113: 537-549.
33. OECD. Guidelines for testing of chemicals. Test no. 432: In vitro 3T3 NRU phototoxicity test, Paris 2004; 1-15.